| [1] |
Sheffield JM, Karcher NR, Barch DM.Cognitive deficits in psychotic disorders：a lifespan perspective[J]. Neuropsychol Rev， 2018， 28(4):509-533.DOI： 10.1007/s11065-018-9388-2.
|
| [2] |
Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery，part 1：test selection，reliability，and validity[J]. Am J Psychiatry， 2008， 165(2):203-213.DOI： 10.1176/appi.ajp.2007.07010042.
|
| [3] |
Mihaljević-Peleš A, Bajs Janović M, Šagud M, et al. Cognitive deficit in schizophrenia：an overview[J].Psychiatr Danub，2019，31(Suppl 2):139-142.
|
| [4] |
Zanelli J, Reichenberg A, Sandin S，et al.Dynamic and static cognitive deficits in schizophrenia and bipolar disorder after the first episode[J]. Schizophr Bull， 2022， 48(3):590-598.DOI： 10.1093/schbul/sbab150.
|
| [5] |
Wang DM, Du YX, Zhu RR，et al.The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia[J]. World J Biol Psychiatry， 2022， 23(7):517-524.DOI： 10.1080/15622975.2021.2013093.
|
| [6] |
Xie YJ, Xi YB, Cui LB，et al.Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia[J]. Psychiatry Res， 2021(300):113937.DOI： 10.1016/j.psychres.2021.113937.
|
| [7] |
Hintze B, Rowicka M, Barczak A．Are executive functions deficits in early-onset chronic schizophrenia more severe than in adult-onset chronic schizophrenia？[J]. Clin Neuropsychiatry， 2022， 19(1):54-63.DOI： 10.36131/cnfioritieditore20220108.
|
| [8] |
|
| [9] |
Van Haren N, Van Dam DS, Stellato RK.Change in IQ in schizophrenia patients and their siblings：a controlled longitudinal study[J]. Psychol Med， 2019， 49(15):2573-2581.DOI： 10.1017/S0033291718003537.
|
| [10] |
Zanelli J, Mollon J, Sandin S，et al.Cognitive change in schizophrenia and other psychoses in the decade following the first episode[J]. Am J Psychiatry， 2019， 176(10):811-819.DOI： 10.1176/appi.ajp.2019.18091088.
|
| [11] |
Fett AJ, Velthorst E, Reichenberg A，et al.Long-term changes in cognitive functioning in individuals with psychotic disorders：findings from the suffolk county mental health project[J]. JAMA Psychiatry， 2020， 77(4):387-396.DOI： 10.1001/jamapsychiatry.2019.3993.
|
| [12] |
Sosin D, Ivashchenko D, Sozaeva Z，et al.Cognitive impairment in patients with treatment resistant schizophrenia：associations with DRD2，DRD3，HTR2A，BDNF and CYP2D6 genetic polymorphisms[J]. Neurology，Psychiatry and Brain Research， 2019， 33(6):48-55.DOI： 10.1016/j.npbr.2019.06.003.
|
| [13] |
Hubbard L, Tansey KE, Rai D，et al.Evidence of common genetic overlap between schizophrenia and cognition[J]. Schizophr Bull， 2016， 42(3):832-842.DOI： 10.1093/schbul/sbv168.
|
| [14] |
Koch E, Nyberg L, Lundquist A，et al.Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals[J]. Transl Psychiatry， 2021， 11(1):520.DOI： 10.1038/s41398-021-01649-4.
|
| [15] |
Perkins DO, Olde Loohuis L, Barbee J，et al.Polygenic risk score contribution to psychosis prediction in a target population of persons at clinical high risk[J]. Am J Psychiatry， 2020， 177(2):155-163.DOI： 10.1176/appi.ajp.2019.18060721.
|
| [16] |
Shafee R, Nanda P, Padmanabhan JL，et al.Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls[J]. Transl Psychiatry， 2018， 8(1):78.DOI： 10.1038/s41398-018-0124-8.
|
| [17] |
He Q, Jantac Mam-Lam-Fook C, Chaignaud J，et al.Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis[J]. Transl Psychiatry， 2021， 11(1):518.DOI： 10.1038/s41398-021-01624-z.
|
| [18] |
Germine L, Robinson EB, Smoller JW，et al.Association between polygenic risk for schizophrenia，neurocognition and social cognition across development[J]. Transl Psychiatry， 2016， 6(10):e924.DOI： 10.1038/tp.2016.147.
|
| [19] |
Su X, Qiao L, Liu Q, et al. Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia[J]. Sci Rep， 2021， 11(1):20057.DOI： 10.1038/s41598-021-99510-7.
|
| [20] |
Poddar I, Callahan PM, Hernandez CM，et al.Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats[J]. Pharmacol Biochem Behav， 2020(189):172853.DOI： 10.1016/j.pbb.2020.172853.
|
| [21] |
Park S, Nasrallah HA.The varieties of anomalous self experiences in schizophrenia：splitting of the mind at a crossroad[J]. Schizophr Res， 2014， 152(1):1-4.DOI： 10.1016/j.schres.2013.11.036.
|
| [22] |
Trask CL, Matsui MM, Cohn JR，et al.Anomalous self-experiences in cognition are negatively associated with neurocognitive functioning in schizophrenia[J]. Cogn Neuropsychiatry， 2021， 26(5):307-320.DOI： 10.1080/13546805.2021.1935225.
|
| [23] |
Hernández-García M, Gómez-García M, Sotelo E，et al.Anomalous self-experiences are related to general cognition deficits in schizophrenia[J]. Eur Arch Psychiatry Clin Neurosci， 2021， 271(4):707-712.DOI： 10.1007/s00406-020-01213-z.
|
| [24] |
Kaneko K．Negative symptoms and cognitive impairments in schizophrenia：two key symptoms negatively influencing social functioning[J]. Yonago Acta Med， 2018， 61(2):91-102.DOI： 10.33160/yam.2018.06.001.
|
| [25] |
Tominaga T, Tomotake M, Takeda T，et al.Relationship between social and cognitive functions in people with schizophrenia[J]. Neuropsychiatr Dis Treat， 2018(14):2215-2224.DOI： 10.2147/NDT.S171207.
|
| [26] |
Yeo BT, Krienen FM, Sepulcre J，et al.The organization of the human cerebral cortex estimated by intrinsic functional connectivity[J]. J Neurophysiol， 2011， 106(3):1125-1165.DOI： 10.1152/jn.00338.2011.
|
| [27] |
Gordon EM, Laumann TO, Marek S，et al.Default-mode network streams for coupling to language and control systems[J]. Proc Natl Acad Sci USA， 2020， 117(29):17308-17319.DOI： 10.1073/pnas.2005238117.
|
| [28] |
Smallwood J, Bernhardt BC, Leech R，et al.The default mode network in cognition：a topographical perspective[J]. Nat Rev Neurosci， 2021， 22(8):503-513.DOI： 10.1038/s41583-021-00474-4.
|
| [29] |
Khalil M, Hollander P, Raucher-Chéné D，et al.Structural brain correlates of cognitive function in schizophrenia：a meta-analysis[J]. Neurosci Biobehav Rev， 2022(132):37-49.DOI： 10.1016/j.neubiorev.2021.11.034.
|
| [30] |
Chumakov E, Dorofeikova M, Tsyrenova K，et al.A cross-sectional study on associations between BDNF，CRP，IL-6 and clinical symptoms，cognitive and personal performance in patients with paranoid schizophrenia[J]. Front Psychiatry， 2022(13):943869.DOI： 10.3389/fpsyt.2022.943869.
|
| [31] |
Baek SH, Kim H, Kim JW，et al.Association between peripheral inflammatory cytokines and cognitive function in patients with first-episode schizophrenia[J]. J Pers Med， 2022， 12(7).DOI： 10.3390/jpm12071137.
|
| [32] |
Kogan S, Ospina LH, Kimhy D．Inflammation in individuals with schizophrenia-implications for neurocognition and daily function[J]. Brain Behav Immun， 2018(74):296-299.DOI： 10.1016/j.bbi.2018.09.016.
|
| [33] |
Xiu MH, Yang GG, Tan YL，et al.Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia：relationship to psychopathology[J]. Schizophr Res， 2014， 156(1):9-14.DOI： 10.1016/j.schres.2014.03.024.
|
| [34] |
|
| [35] |
Rokita KI, Dauvermann MR, Mothersill D，et al.Current psychosocial stress，childhood trauma and cognition in patients with schizophrenia and healthy participants[J]. Schizophr Res， 2021(237):115-121.DOI： 10.1016/j.schres.2021.08.030.
|
| [36] |
|
| [37] |
Piotrowski P, Kotowicz K, Rymaszewska J，et al.Allostatic load index and its clinical correlates at various stages of psychosis[J]. Schizophr Res， 2019(210):73-80.DOI： 10.1016/j.schres.2019.06.009.
|
| [38] |
Zhou Y, Huang J, Zhang P，et al.Allostatic load effects on cortical and cognitive deficits in essentially normotensive，normoweight patients with schizophrenia[J]. Schizophr Bull， 2021， 47(4):1048-1057.DOI： 10.1093/schbul/sbaa196.
|
| [39] |
Azimi Sanavi M, Ghazvini H, Zargari M，et al.Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia[J]. Neurosci Lett， 2022(770):136354.DOI： 10.1016/j.neulet.2021.136354.
|
| [40] |
Rogóz Z, Kamińska K, Lech MA，et al.N-acetylcysteine and aripiprazole improve social behavior and cognition and modulate brain BDNF levels in a rat model of schizophrenia[J]. Int J Mol Sci， 2022， 23(4).DOI： 10.3390/ijms23042125.
|
| [41] |
Wu Z, Liu Q, Zhang Y，et al.Superoxide dismutase，BDNF，and cognitive improvement in drug-naive first-episode patients with schizophrenia：a 12-week longitudinal study[J]. Int J Neuropsychopharmacol， 2022， 25(2):128-135.DOI： 10.1093/ijnp/pyab065.
|
| [42] |
Setién-Suero E, Ortiz-García de la Foz V, Suárez-Pinilla P，et al.Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis：a 3-year follow-up comparison[J]. Prog Neuropsychopharmacol Biol Psychiatry， 2021(110):110309.DOI： 10.1016/j.pnpbp.2021.110309.
|
| [43] |
Joshi YB, Thomas ML, Braff DL，et al.Anticholinergic medication burden-associated cognitive impairment in schizophrenia[J]. Am J Psychiatry， 2021， 178(9):838-847.DOI： 10.1176/appi.ajp.2020.20081212.
|
| [44] |
Lindenmayer JP, Insel BJ, Khan A，et al.Effects of clozapine on neurocognitive functions in schizophrenia：a naturalistic comparison to non-clozapine antipsychotics[J].Innov Clin Neurosci，2021，18(10-12):40-46.
|
| [45] |
Singh A, Kumar V, Pathak H，et al.Effect of antipsychotic dose reduction on cognitive function in schizophrenia[J]. Psychiatry Res， 2022(308):114383.DOI： 10.1016/j.psychres.2021.114383.
|
| [46] |
Zhu X, Fan H, Zou Y，et al.Computerized or manual? Long term effects of cognitive remediation on schizophrenia[J]. Schizophr Res， 2022(239):47-54.DOI： 10.1016/j.schres.2021.11.019.
|
| [47] |
Katsumi A, Hoshino H, Fujimoto S, et al. Effects of cognitive remediation on cognitive and social functions in individuals with schizophrenia[J]. Neuropsychol Rehabil， 2019， 29(9):1475-1487.DOI： 10.1080/09602011.2017.1409639.
|
| [48] |
Buonocore M, Spangaro M, Bechi M，et al.Cognitive remediation in schizophrenia：what happens after 10 years？[J]. Schizophr Res Cogn， 2022(29):100251.DOI： 10.1016/j.scog.2022.100251.
|
| [49] |
Khonsari NM, Badrfam R, Mohammdi MR，et al.Effect of aerobic exercise as adjunct therapy on the improvement of negative symptoms and cognitive impairment in patients with schizophrenia：a randomized，case-control clinical trial[J]. J Psychosoc Nurs Ment Health Serv， 2022， 60(5):38-43.DOI： 10.3928/02793695-20211014-03.
|
| [50] |
Wen N, Chen L, Miao X，et al.Effects of high-frequency rTMS on negative symptoms and cognitive function in hospitalized patients with chronic schizophrenia：a double-blind，sham-controlled pilot trial[J]. Front Psychiatry， 2021(12):736094.DOI： 10.3389/fpsyt.2021.736094.
|